Casdin Capital as of Dec. 31, 2020
Portfolio Holdings for Casdin Capital
Casdin Capital holds 51 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Invitae (NVTAQ) | 15.2 | $514M | 12M | 41.81 | |
| Biolife Solutions Com New (BLFS) | 8.8 | $297M | 7.4M | 39.89 | |
| Fate Therapeutics (FATE) | 8.2 | $277M | 3.1M | 90.93 | |
| EXACT Sciences Corporation (EXAS) | 5.8 | $197M | 1.5M | 132.49 | |
| Blueprint Medicines (BPMC) | 5.1 | $174M | 1.6M | 112.15 | |
| Relay Therapeutics (RLAY) | 4.7 | $158M | 3.8M | 41.56 | |
| Twist Bioscience Corp (TWST) | 4.2 | $141M | 1.0M | 141.29 | |
| Pacific Biosciences of California (PACB) | 3.8 | $130M | 5.0M | 25.94 | |
| Denali Therapeutics (DNLI) | 3.3 | $110M | 1.3M | 83.76 | |
| Agios Pharmaceuticals (AGIO) | 3.0 | $103M | 2.4M | 43.33 | |
| Alnylam Pharmaceuticals (ALNY) | 3.0 | $101M | 780k | 129.97 | |
| Codexis (CDXS) | 2.8 | $95M | 4.3M | 21.83 | |
| Sarepta Therapeutics (SRPT) | 2.7 | $90M | 530k | 170.49 | |
| Caredx (CDNA) | 2.6 | $87M | 1.2M | 72.45 | |
| Revolution Medicines (RVMD) | 1.9 | $65M | 1.6M | 39.59 | |
| Constellation Pharmceticls I | 1.5 | $51M | 1.8M | 28.80 | |
| Generation Bio | 1.4 | $46M | 1.6M | 28.35 | |
| Dermtech Ord ord (DMTKQ) | 1.3 | $44M | 1.4M | 32.44 | |
| Burning Rock Biotech Sponsored Ads | 1.3 | $44M | 1.9M | 23.10 | |
| Adaptive Biotechnologies Cor (ADPT) | 1.2 | $42M | 713k | 59.13 | |
| Crispr Therapeutics Namen Akt (CRSP) | 1.2 | $41M | 266k | 153.11 | |
| Bluebird Bio | 1.2 | $40M | 915k | 43.27 | |
| Adverum Biotechnologies | 1.2 | $40M | 3.7M | 10.84 | |
| Beigene Sponsored Adr (ONC) | 1.1 | $39M | 150k | 258.39 | |
| Beam Therapeutics (BEAM) | 1.1 | $38M | 460k | 81.64 | |
| Global Blood Therapeutics In | 1.1 | $37M | 860k | 43.31 | |
| 4d Molecular Therapeutics In (FDMT) | 1.0 | $32M | 781k | 41.45 | |
| Magenta Therapeutics | 0.8 | $26M | 3.3M | 7.84 | |
| Zai Lab Adr (ZLAB) | 0.8 | $26M | 190k | 135.34 | |
| Iovance Biotherapeutics (IOVA) | 0.8 | $26M | 550k | 46.40 | |
| Alector (ALEC) | 0.7 | $25M | 1.7M | 15.13 | |
| Allogene Therapeutics (ALLO) | 0.7 | $24M | 945k | 25.24 | |
| 908 Devices (MASS) | 0.7 | $23M | 407k | 56.95 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.6 | $22M | 820k | 26.54 | |
| Oric Pharmaceuticals (ORIC) | 0.6 | $20M | 602k | 33.85 | |
| Berkeley Lts | 0.5 | $18M | 200k | 89.41 | |
| Kronos Bio | 0.5 | $17M | 583k | 29.87 | |
| Sangamo Biosciences (SGMO) | 0.5 | $17M | 1.1M | 15.60 | |
| Fulcrum Therapeutics (FULC) | 0.4 | $15M | 1.2M | 11.71 | |
| Amyris Call Option | 0.4 | $12M | 2.0M | 6.17 | |
| Syndax Pharmaceuticals (SNDX) | 0.3 | $10M | 450k | 22.24 | |
| Black Diamond Therapeutics (BDTX) | 0.3 | $9.3M | 289k | 32.05 | |
| Turning Point Therapeutics I | 0.3 | $9.1M | 75k | 121.85 | |
| Seer Com Cl A (SEER) | 0.2 | $8.4M | 150k | 56.14 | |
| Abcellera Biologics (ABCL) | 0.2 | $8.0M | 200k | 40.24 | |
| Dyne Therapeutics (DYN) | 0.2 | $7.8M | 370k | 21.00 | |
| Stoke Therapeutics (STOK) | 0.2 | $7.4M | 120k | 61.93 | |
| Foghorn Therapeutics (FHTX) | 0.1 | $4.4M | 216k | 20.27 | |
| Bristol-myers Squibb Right 99/99/9999 | 0.1 | $4.3M | 6.3M | 0.69 | |
| Codiak Biosciences | 0.1 | $2.5M | 77k | 32.30 | |
| C4 Therapeutics Com Stk (CCCC) | 0.0 | $1.3M | 40k | 33.12 |
